In contrast to the aforementioned tumorigenic functions of PGC-1α, the diminution of PGC-1α indirectly by HIF renders metabolic reprogramming, accelerating tumorigenesis and the resistance to chemotherapies in RCC cells (150). Here, PPARGC1A is linked to renal cell carcinoma.